期刊文献+

银杏内酯B对动脉粥样硬化家兔模型血清CRP和主动脉VCAM-1 mRNA的影响 被引量:5

Effects of ginkgolide B on serum CRP and aortic VCAM-1 mRNA in rabbit with atherosclerosis
下载PDF
导出
摘要 [目的]探讨银杏内酯B(EGB)对动脉粥样硬化家兔模型血清反应蛋白(CRP)含量和主动脉血管细胞黏附分子-1(VCAM-1mRNA)表达的影响。[方法]通过高脂饲料喂养8周复制动脉粥样硬化家兔模型,将35只家兔随机分为对照组、模型组和银杏内酯B组,8周后,银杏内酯B组加喂EGB 5 mg(/kg.d),继续喂养8周。处死前耳缘静脉取血,采用ELISA法检测血清CRP含量;处死后取主动脉,采用实时定量PCR法检测VCAM-1 mR-NA表达。[结果]模型组血清CRP含量比对照组升高,银杏内酯B组血清CRP含量降低,与模型组相比两组差异均有显著性,P<0.01。模型组VCAM-1 mRNA表达比对照组升高,银杏内酯B组VCAM-1 mRNA表达降低,与模型组相比两组差异均有显著性,P<0.01。[结论]银杏内酯B能够降低动脉粥样硬化家兔模型血清CRP含量,有效抑制动脉粥样硬化家兔模型主动脉VCAM-1 mRNA表达,从而起到防治动脉粥样硬化的目的。 [Objective] To explore the effect of ginkgolides B on the content of serum CRP and the expression of aortic VCAM 1-gene in rabbits with atherosclerosis.[Methods] High fat feed was use to induce rabbit model of atherosclerosis.Thirty-five rabbits were divided into control(ordinary),model group,and ginkgolides B group,the last two groups were given high fat feed for eight weeks.After that the rabbits in ginkgolides B group were fed with EGB,5 mg/(kg.d).They were continued to feed for another eight weeks.Blood sample was extracted from ear margin vein before death.Enzyme-linked immunosorbent assay(ELISA) was used to detect the rabbit serum CRP levels.After death,a sample of aortic artery was taken to detect VACM-1 gene expression by PCR method.[Results] The CRP levels of model group was obviously higher than that of control group;serum CRP content of ginkgolides B group was lower than that of model group.There was a significant difference between both groups(P0.01).VCAM-1 gene expression in model group was higher than control,ginkgolides B group was lower than model group,obviously difference was found between two groups(P0.01).[Conclusion] Ginkgolides B can reduce serum CRP levels in rabbits with atherosclerosis,inhibit the aortic VCAM-1 gene expression effectively,thus Preventing the development of arteriosclerosis.
机构地区 天津中医药大学
出处 《天津中医药大学学报》 CAS 2010年第2期84-86,共3页 Journal of Tianjin University of Traditional Chinese Medicine
基金 天津市自然科学基金(08JCYBJC10800) 天津市卫生局基金(09KZ115)
关键词 动脉粥样硬化 银杏内酯B C反应蛋白 血管细胞黏附分子-1 Atherosclerosis Ginkgolide B CRP VCAM-1
  • 相关文献

参考文献6

  • 1赵宇,黄绍烈,黄剑锋.炎症与动脉粥样硬化[J].实用中西医结合临床,2009,9(4):92-94. 被引量:7
  • 2Ridker PM.High-sensitivity C-reactive protein:potential adjunct for Global risk assessmentin the primary prevention of cardiovascular disease[J].Circulation,2001,103:1813-1818.
  • 3Takahisa Murata,Masatoshi Hori,et al.Vaseular Endothelium Has a Local Anti-Adenovirus Vector System and Glucocorticoid Optimizes Its Gene Transduction [J]. Arteriosclerosis, Thrombosis,and Vascular Biology, 2005, 25:1796-1803.
  • 4Livak KJ,Schmittgen TD.Analysis of Relative Gene Expres- sio Data Using Real-Time Quantitative PCR and the 2-ΔΔCT- Method[J].Methods ,2001, 25:402-408.
  • 5梁克山,谭兰.C反应蛋白与动脉粥样硬化性疾病的关系研究及进展[J].中华神经医学杂志,2007,6(6):643-646. 被引量:15
  • 6Wilson AM,Ryan MC,Boyle AL.The novel role of C-reactive protein in cardiovasculardisease: risk maker or pathogen[J].Int J Cardio,1 2006, 106 (3):291-297.

二级参考文献41

  • 1邱宇安,黄绍烈,陈岳青,陈文学,黄秀珍.血管紧张素Ⅱ对内皮细胞致凋亡效应及血脂康的保护作用[J].江西医学院学报,2005,45(2):11-14. 被引量:4
  • 2聂志华,黄绍烈.胰岛素与动脉粥样硬化[J].江西医药,2007,42(3):262-264. 被引量:2
  • 3Ross R.Atherosclerosis: an inflammatory disease [J].N Engl J Med, 1999,340(2):115-126.
  • 4Libby P,Ridker PM,Maseri A.Inflammation in atherosclcrosis [J]. Circulation,2002,105(9):1 135-1 143.
  • 5Boyle JJ.Macrophage activation in atherosclerosis: Pathogenesis andpharmacology of plaque rupture [J].CurrVasc Pharmacol,2005,3(1): 63 -68.
  • 6DeGraba TJ.Immtmogenetic suspectibility of atherosclerotic slroke. Implications on current and future treatment of vaselular inflammation[J]. Stroke,2004, 35(suppll):2 712-2 719.
  • 7Latkovskis G, Licis N, Kalnins U. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease [J].Eur J Immunogenet,2004,31 (5): 207-213.
  • 8Dubravec DB, Spriggs DILMannick JA, et al.Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha[J].Proc Natl Acad Sci USA,1990,87:6 758-6 761.
  • 9Ishai L,RonniG,David P, et al.Elevatcd levels of CRP in ovarian hyperstimulation syndrome: an unrecognised potential hazard [J]. B JOG,2005,112(7):952-955.
  • 10Pau E,Alonso-Muriel I, Go mez R, et al.Plasma levels of soluble vascular endothelial growth factor receptor-I may determine the onset of early and late ovarian hyperstimulation syndrome [J].Hum Reprod,2006,21(6):1 453-1 460.

共引文献20

同被引文献43

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部